Neuronal hyperactivity at the spinal cord and periaqueductal grey during painful diabetic neuropathy: Effects of gabapentin
- 1 August 2010
- journal article
- Published by Wiley in European journal of pain
- Vol. 14 (7) , 693-699
Abstract
Painful diabetic neuropathy may be due to impairments in descending modulation of nociceptive transmission at the spinal cord. In the present study, streptozotocin diabetic rats (STZ rats) with neuropathic symptoms (mechanical hypersensitivity) were used to perform a time‐course evaluation of neuronal activity at the spinal dorsal horn and at the periaqueductal grey matter (PAG), a major brainstem area of pain modulation. The expression of Fos protein, a marker of nociceptive activation, progressively increased at the spinal dorsal horn at 4 and 10 weeks. At the PAG, increases in Fos expression were detected until the 4th week, with a reversal to baseline values at 10 weeks in all areas except the ventrolateral PAG. Co‐localisation of Fos with NeuN ascertained the neuronal nature of Fos‐expressing cells at the spinal cord and PAG. Four weeks after diabetes induction, the effects of gabapentin (i.p. injection of 50 mg/kg, daily during 3 days) were assessed. Gabapentin decreased Fos expression at the spinal cord and PAG and reversed mechanical hypersensitivity. The present study shows that diabetic neuropathy is accompanied by a progressive increase of the spontaneous neuronal activity at the spinal cord. Changes in descending modulation of nociceptive transmission from the PAG are likely to occur during diabetic neuropathy, probably with exacerbation of facilitatory actions. The effects of gabapentin in reversing the behavioural signs of diabetic neuropathy and neuronal hyperactivity in the spinal cord and PAG reinforce the central causes of diabetic neuropathy and point to the central targets of the drug.Keywords
This publication has 61 references indexed in Scilit:
- Predicting therapeutic efficacy — Experimental pain in human subjectsBrain Research Reviews, 2009
- Gabapentin Acts within the Locus Coeruleus to Alleviate Neuropathic PainAnesthesiology, 2008
- Diabetes affects the expression of GABA and potassium chloride cotransporter in the spinal cord: A study in streptozotocin diabetic ratsNeuroscience Letters, 2008
- Pro-nociceptive action of cholecystokinin in the periaqueductal grey: A role in neuropathic and anxiety-induced hyperalgesic statesNeuroscience & Biobehavioral Reviews, 2008
- Concurrent activation of the somatosensory forebrain and deactivation of periaqueductal gray associated with diabetes-induced neuropathic painExperimental Neurology, 2007
- Neuronal activation at the spinal cord and medullary pain control centers after joint stimulation: A c-fos study in acute and chronic articular inflammationNeuroscience, 2007
- Global and Regional Effects of Type 2 Diabetes on Brain Tissue Volumes and Cerebral VasoreactivityDiabetes Care, 2007
- Spinal-cord involvement in diabetic peripheral neuropathyThe Lancet, 2001
- Periaqueductal gray matter stimulation-produced analgesia in diabetic ratsNeuroscience Letters, 1992
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983